- $27.51bn
- $25.54bn
- $5.23bn
- 96
- 36
- 97
- 90
2019 December 28th | 2020 December 26th | 2021 December 25th | 2022 December 31st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,758 | 4,187 | 4,983 | 4,860 | 5,228 |
Cost of Revenue | |||||
Gross Profit | 2,234 | 2,481 | 2,890 | 2,807 | 3,005 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 2,812 | 3,132 | 3,764 | 3,832 | 4,136 |
Operating Profit | 946 | 1,054 | 1,219 | 1,028 | 1,092 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 987 | 1,103 | 1,207 | 1,065 | 1,200 |
Provision for Income Taxes | |||||
Net Income After Taxes | 952 | 992 | 1,082 | 974 | 1,290 |
Net Income Before Extraordinary Items | |||||
Net Income | 952 | 992 | 1,082 | 974 | 1,290 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 952 | 992 | 1,082 | 974 | 1,290 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.99 | 5.17 | 5.61 | 5.04 | 6.71 |
Dividends per Share |